Solvay

Corporate brand

Belgian multinational chemical company focused on essential chemistry, including soda ash, peroxides, silica, fluorine products, rare earths, solvents, and related industrial materials.

Last updated November 4, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

Solvay is a Belgian multinational chemical company whose modern business is centered on essential chemistry: large-scale and specialized products that serve glassmaking, construction, food and healthcare, water and air treatment, electronics, automotive, energy, and other industrial markets. The company is headquartered in Brussels and remains listed on Euronext Brussels and Euronext Paris under the ticker SOLB. The company was founded in 1863 by brothers Ernest and Alfred Solvay to industrialize Ernest Solvay’s ammonia-soda process for manufacturing sodium carbonate, commonly known as soda ash. Soda ash became a fundamental industrial material for glass, detergents, metallurgy, chemicals, and other applications. Solvay’s early advantage came not only from the process itself but also from a distinctive international expansion model. By the late nineteenth and early twentieth centuries, the group had established plants, partnerships, and affiliated companies across Europe, the United States, and Russia, making it one of the earliest genuinely multinational industrial companies. For much of its history, Solvay was associated with soda ash and heavy chemicals, but it progressively diversified into plastics, pharmaceuticals, specialty chemicals, fibers, fluorinated products, and advanced materials. The company’s portfolio changed substantially in the early twenty-first century. It sold its pharmaceutical division to Abbott Laboratories in a transaction announced in 2009 and completed in 2010, then used the proceeds and its balance-sheet capacity to acquire Rhodia in 2011. Rhodia expanded Solvay’s exposure to consumer products, automotive applications, rare earths, specialty chemicals, and other higher-value activities. In 2015, Solvay completed its acquisition of Cytec Industries, adding major aerospace and industrial composite materials and mining-chemicals businesses. A further strategic reorganization took effect in December 2023, when Solvay separated its specialty-chemicals and advanced-materials activities into the separately listed company Syensqo. Solvay retained the essential-chemistry portfolio, including soda ash and bicarbonates, peroxides, silica, selected fluorine activities, rare earths, oxygenated solvents, and regional chemical businesses. The separation was intended to give the two companies more focused strategies and operating models. After the transaction, Solvay became a more concentrated producer of critical chemical inputs rather than the broader specialty-materials group it had been before the demerger. Solvay’s current positioning combines scale, process technology, market leadership, cost discipline, and sustainability. Its products are generally sold business-to-business rather than directly to consumers, although Solvay brands and ingredients can appear in glass, detergents, toothpaste, tires, food packaging, healthcare equipment, electronics, and environmental-control systems. Important current technologies include the Solvay ammonia process for synthetic soda ash, high-purity hydrogen peroxide for industrial and semiconductor applications, precipitated silica for tires and other formulations, sodium bicarbonate for emissions control and healthcare, and rare-earth separation and formulation technologies. The company also emphasizes lower-impact production and circular or renewable chemistry. Examples include circular silica for tires, bio-based solvents, energy-efficiency projects at production sites, environmental applications based on sodium bicarbonate, and the development of European rare-earth capacity for permanent magnets. Solvay has stated a long-term ambition to reduce its environmental footprint and support a transition toward carbon-neutral operations. Its current strategy describes the group as a leader in Essential Chemistry, with products intended to support everyday necessities and industrial infrastructure. As reported in Solvay’s 2025 annual integrated report, the post-demerger…

History

Solvay was established in 1863 by Ernest Solvay and his brother Alfred to commercialize Ernest’s ammonia-soda process for producing sodium carbonate. The process used salt, ammonia, limestone, and carbon dioxide to manufacture soda ash more efficiently than the older Leblanc process. Solvay’s first industrial plant was built at Couillet in Belgium, in the Charleroi industrial region. After early technical difficulties, the company achieved rapid growth and began extending its production model beyond Belgium. During the late nineteenth century, Solvay became one of the earliest multinational industrial groups. It developed wholly owned plants, partnerships, and affiliated companies in countries including Britain, Germany, Austria-Hungary, the United States, and Russia. The group’s international structure allowed it to transfer technical knowledge, coordinate production, and establish a strong position in the growing glass and chemical industries. By the early twentieth century, Solvay had become one of the world’s largest chemical groups by workforce and output. Its historical shareholder base was closely associated with the founding families and their partners, a structure that endured for decades. The company survived the disruption of the two World Wars and resumed international expansion after 1945. From the 1950s onward, Solvay diversified beyond soda ash into plastics, pharmaceuticals, fibers, chemical intermediates, and other materials. This diversification reflected the growing importance of synthetic materials and the company’s effort to reduce dependence on a single heavy-chemical product. Solvay also supported the Solvay Conferences, scientific meetings founded by Ernest Solvay in 1911 that became important forums for leading physicists and chemists. From the 1970s through the 1990s, Solvay expanded its presence in Asia and developed a more complex portfolio of chemicals, plastics, and pharmaceutical products. The group increasingly focused on technologies with higher added value. In the early 2000s, it sold its polyolefins activities to BP and acquired engineering-plastics capabilities in return. It also combined fluorinated-polymer activities with those of Ausimont, creating Solvay Solexis in 2003 and strengthening its position in fluorine chemistry. A decisive transformation began in 2009. Solvay sold its pharmaceutical division to Abbott Laboratories for approximately €4.5 billion, completing the transaction in February 2010. The divestment provided resources for a renewed focus on chemicals and materials. In 2011, Solvay acquired the French chemical company Rhodia for approximately €3.4 billion. Rhodia brought businesses in specialty chemicals, consumer markets, automotive applications, rare earths, and other fields. Jean-Pierre Clamadieu, previously Rhodia’s chief executive, became Solvay’s chief executive in 2012, marking the first time the company was led by a chief executive whose career had been built outside the historic Solvay organization. The Rhodia integration was followed by a period of portfolio reshaping, international expansion, and increased emphasis on specialty and advanced materials. In 2015, Solvay agreed to acquire Cytec Industries, a United States-based chemicals and materials company. The transaction was completed in December 2015 and became the largest acquisition in Solvay’s history. Cytec strengthened the group’s aerospace and automotive composite-materials businesses and added mining chemicals and other specialty formulations. To finance the deal, Solvay carried out a major share issue and used additional hybrid and debt financing. Solvay also developed a public innovation and sustainability profile through its long partnership with the Solar Impulse project. From 2004 to 2016, the company supplied polymers, engineering plastics, battery materials, photovoltaic-related materials, lightweight components, and other technologies used in the solar-powered aircraft. Solar Impulse’s first test flight took place in 2009, and Solar Impulse 2 subsequently completed a solar-powered circumnavigation of the globe in 2015–2016. The project became a prominent demonstration of Solvay’s technology-led approach to energy efficiency and lightweighting. In 2022, Solvay announced a plan to separate its business into two independent companies. The transaction was approved by shareholders in 2023 and completed in December of that year. The specialty-chemicals and advanced-materials activities became Syensqo, while Solvay retained the essential-chemistry portfolio. The separation changed the company’s identity from a diversified chemicals and advanced-materials group into a more focused operator centered on soda ash and bicarbonates, peroxides, silica, fluorine-related activities, rare earths, oxygenated solvents, and selected regional chemical businesses. Since the demerger, Solvay has pursued a strategy built around essential chemistry, process innovation, operational efficiency, and sustainability. It has invested in lower-impact soda-ash and peroxide production, circular silica, bio-based solvents, emissions-control technologies, and European rare-earth production. In 2024, the La Rochelle site in France expanded its capacity to produce rare-earth materials for permanent magnets. The company has also taken steps to stop or phase out TFA-related activities and has disclosed restructuring actions affecting selected German operations. At the end of 2025, Solvay remained a listed Belgian chemical company with a global industrial footprint and a portfolio aimed at supplying materials essential to everyday life and strategic industrial sectors.

2025
Post-demerger restructuring is disclosed
[4]Solvay 2025 Annual Integrated Reportsolvay.com
Solvay discloses selected product discontinuations at Bad Wimpfen and plans for the Garbsen site to cease operations by 2028.
2024
La Rochelle rare-earth expansion begins
[9]Solvay rare-earth production expansionsolvay.com
Solvay inaugurates a production line for rare-earth materials used in permanent magnets and strategic clean-technology applications.
2024
TFA production stops at Salindres
[2]Solvay official company overviewsolvay.com
Solvay reports that production of trifluoroacetic acid stopped at its Salindres site in France in September 2024.
2023
Syensqo separation is completed
[5]Solvay partial demerger informationsolvay.com
The partial demerger is completed in December, leaving Solvay focused on essential chemistry and placing specialty activities in Syensqo.
2022
Separation plan is announced
[5]Solvay partial demerger informationsolvay.com
Solvay announces its intention to separate essential-chemistry activities from specialty chemicals and advanced materials.
2016
Solar Impulse completes a solar-powered circumnavigation
[14]Transformation into a public companysolvay.com
Solar Impulse 2 completes its around-the-world flight, highlighting technologies supplied or developed with Solvay’s support.
2015
Cytec acquisition is announced and financed
[7]Solvay Cytec acquisition announcementsolvay.com
Solvay announces the approximately US$5.5 billion acquisition of Cytec and launches a share issue and additional financing to fund the transaction.
2015
Cytec acquisition closes
[8]Solvay Cytec acquisition completion announcementsolvay.com
Solvay completes the Cytec acquisition, gaining aerospace and industrial composites, mining chemicals, and other specialty businesses.
2012
Solvay joins the CAC 40
[12]Wikipedia article: Solvay S.A.en.wikipedia.org
Following the Rhodia integration and Paris listing, Solvay joins the CAC 40 index in September 2012.
2011
Rhodia acquisition is completed
[14]Transformation into a public companysolvay.com
Solvay acquires French chemical company Rhodia, adding specialty chemicals, rare earths, consumer-market materials, and automotive-related businesses.
2009
Pharmaceutical division sale is announced
[14]Transformation into a public companysolvay.com
Solvay agrees to sell its pharmaceutical business to Abbott Laboratories, completing the transaction in 2010.
2003
Solvay Solexis is created
[15]Polyolefins are divestedsolvay.com
Fluorinated-polymer activities from Solvay and Ausimont are combined, strengthening Solvay’s position in fluorine products.
2001
Polyolefins are divested
[15]Polyolefins are divestedsolvay.com
Solvay sells its polyolefins activities to BP and acquires engineering-plastics activities, supporting a shift toward higher-value materials.
1967
Transformation into a public company
[14]Transformation into a public companysolvay.com
Solvay becomes a public company after a long period in which ownership and management were closely associated with the founding families.
1911
Solvay Conferences begin
[12]Wikipedia article: Solvay S.A.en.wikipedia.org
The first Solvay Conference is organized, creating a lasting forum for international scientific exchange.
1900
Soda-ash process reaches global dominance
[1]Solvay official company historysolvay.com
Solvay states that approximately 95 percent of the world’s soda ash was being produced using the Solvay process at the turn of the century.
1881
Expansion into the United States
[13]Solvay is foundedsolvay.com
Solvay establishes an early United States presence and begins producing soda ash at the Syracuse, New York, site.
1877
First major Belgian industrial plant
[13]Solvay is foundedsolvay.com
Solvay builds its first industrial plant at Couillet in the Charleroi region, an important center of glass production and heavy industry.
1863
Solvay is founded
[13]Solvay is foundedsolvay.com
Ernest and Alfred Solvay establish the company to industrialize the ammonia-soda process for producing sodium carbonate.

Products and positioning

A global essential-chemistry company combining large-scale production, process know-how, market leadership, and sustainability-oriented innovation.

Soda ash and sodium carbonate · 1863
Soda Solvay
Soda Solvay is Solvay’s soda-ash range, based on sodium carbonate produced through synthetic ammonia-soda chemistry or refined from natural trona. Dense and light grades serve different handling and formulation requirements. The material is a major input for container and flat glass, detergents, chemical processing, metallurgy, pulp and paper, water treatment, and selected pharmaceutical applications. It remains the historical foundation of the Solvay business.
Sodium bicarbonate
BICAR
BICAR is Solvay’s sodium-bicarbonate platform. Its grades are used in healthcare, food, animal nutrition, personal care, cleaning, and industrial processing. Sodium bicarbonate can act as a buffering, neutralizing, cleaning, or treatment agent. Solvay highlights applications including hemodialysis, pharmaceutical formulations, dental products, flue-gas treatment, and environmental-control systems.
Air-pollution control
SOLVAir solutions
SOLVAir solutions use sodium bicarbonate-based products and related services to remove acidic pollutants from industrial and waste-to-energy flue gases. The product family is designed to neutralize substances such as sulfur dioxide, hydrogen chloride, hydrogen fluoride, and other acid gases. It combines chemical products with application expertise, dosing approaches, consulting, and residue-management support.
Hydrogen peroxide and peroxygen chemistry
Peroxygens
Solvay’s peroxygen portfolio is led by hydrogen peroxide and related oxidizing products. These materials are supplied to pulp and paper, textile, chemical manufacturing, water treatment, electronics, battery recycling, and urban-mining applications. High-purity grades are important in semiconductor cleaning and etching, while other grades support bleaching, oxidation, disinfection, and environmental processes.
Precipitated silica · 1990
Tixosil
Tixosil is a range of precipitated silicas used in tires, oral care, food, feed, coatings, rubber, and formulated consumer products. Solvay describes itself as a pioneer and global technology leader in high-performance silica. Its silica technologies can contribute to tire safety, rolling-resistance reduction, durability, polishing, cleaning, and other formulation properties.
Rare earths and metal oxides · 1948
Rare-earth products and formulations
Solvay produces separated rare-earth materials and formulations for automotive catalysts, pollution control, polishing, electronics, hydrogen-related applications, and permanent magnets. The La Rochelle facility in France is a central asset in this business and has been expanded to support European supply of rare earths used in electric-vehicle motors, wind turbines, advanced electronics, and defense systems.
Fluorine chemistry · 2003
Fluorine chemicals
Solvay retains selected fluorine-related activities after the 2023 separation, although many specialty fluoropolymers and advanced-materials activities moved to Syensqo. The remaining portfolio includes fluorine intermediates and products used in industrial, chemical, and high-performance applications. Solvay has also undertaken changes to TFA-related production and selected European fluorine operations.
Solvents
Augeo and oxygenated solvents
Solvay’s oxygenated-solvent portfolio includes conventional and bio-based materials for home care, air care, personal care, coatings, inks, leather, and industrial formulations. Products such as Augeo and sugarcane-derived ethyl acetate are positioned as lower-impact alternatives in selected applications, offering solvency, odor, evaporation, and formulation characteristics suited to consumer and industrial products.
Renewable-feedstock process technology
Epicerol process
Epicerol is Solvay’s process for producing epichlorohydrin from natural glycerin rather than relying solely on conventional fossil-based feedstocks. The technology was developed to create a more renewable route to an important chemical intermediate used in epoxy resins and other applications. It represents Solvay’s broader effort to combine process innovation with renewable raw materials.
Soil and residue remediation
Novosol process
Novosol is a sodium-bicarbonate-based process for treating mineral residues contaminated with heavy metals. The technology is intended to stabilize or recover contaminated materials and support their subsequent handling or reuse. It illustrates Solvay’s application of bicarbonate chemistry beyond conventional industrial production, particularly in environmental remediation and residue management.

Controversies

2021
Delaware environmental investigation agreement
Delaware reached an agreement with Solvay Specialty Polymers concerning an investigation into potential PFAS contamination. Solvay denied responsibility, while the agreement required environmental investigation under the supervision of the Delaware Department of Natural Resources and Environmental Control.
Source
2020
PFAS contamination litigation in New Jersey
New Jersey filed natural-resource-damage and cleanup lawsuits against Solvay Specialty Polymers USA and Arkema concerning alleged PFAS contamination associated with a Gloucester County manufacturing facility. The state complaint alleged releases of PFAS compounds, including PFNA, into surrounding environmental media and public drinking-water sources. Solvay Specialty Polymers became part of Syensqo after the 2023 separation, so the litigation concerns a business historically associated with Solvay rather than the current essential-chemistry operating portfolio.
Source

2024Essential for Generations
Global
Following the creation of Syensqo, Solvay emphasized the purpose and positioning of the remaining company as an essential-chemistry producer supporting everyday life, resource efficiency, cleaner mobility, environmental protection, and sustainable industrial development.
Outcome. The campaign and corporate platform clarified Solvay’s post-demerger identity and connected its portfolio of soda ash, peroxides, silica, rare earths, solvents, and related technologies with long-term sustainability goals.
Source
2017World Alliance for Efficient Solutions
Global
Solvay joined the World Alliance for Efficient Solutions, created by Solar Impulse founder Bertrand Piccard to promote technologies and systems intended to improve quality of life while reducing resource use and environmental impact.
Outcome. The initiative extended Solvay’s Solar Impulse engagement into a broader public platform for efficient technologies, open innovation, and sustainability-oriented industrial solutions.
Source
2004Solar Impulse technology partnership
Global · Europe · North America · Asia-Pacific
Solvay became a principal technology partner of the Solar Impulse project, contributing research, polymers, engineering plastics, lightweighting materials, battery-related components, photovoltaic-related materials, and other products to the solar-powered aircraft.
Outcome. The partnership supported Solar Impulse’s first test flight in 2009, later solar-powered flights across continents, and Solar Impulse 2’s around-the-world flight completed in 2016. It also gave Solvay a high-profile platform for communicating its innovation and sustainable-mobility strategy.
Source

Brand decisions

2025
Restructure selected German fluorine operationsStrategy
Background
Solvay’s 2025 portfolio review identified product lines at Bad Wimpfen for discontinuation and determined that operations at Garbsen would be reallocated or eventually closed.
Action taken
The company announced discontinuation of selected TFA-related organics and some inorganic products, relocation of Nocolok technology and production operations, and a planned Garbsen shutdown by 2028.
Aftermath
Solvay recorded a restructuring provision of approximately €20 million in the third quarter of 2025 and continued implementing the post-demerger portfolio strategy.
Restructuring provision. Approximately €20 million recorded in Q3 2025 (2025)
Source
2024
Expand European rare-earth capacityStrategy
Background
European industrial policy and demand for electric vehicles, wind turbines, electronics, and defense systems increased the strategic importance of rare-earth supply chains.
Action taken
Solvay expanded its La Rochelle, France, facility and inaugurated a production line for rare-earth materials used in permanent magnets.
Aftermath
The project positioned La Rochelle as a major non-Chinese rare-earth separation and formulation site and enabled commercial production for permanent-magnet applications.
Source
2024
Stop and phase out TFA-related productionGeneration change
Background
Solvay reviewed its fluorine portfolio in the context of environmental concerns, regulatory scrutiny, and the post-demerger division of responsibilities between Solvay and Syensqo.
Action taken
The company stopped TFA production at Salindres in September 2024 and stated that remaining TFA-related production at Bad Wimpfen would be phased out by early 2026.
Aftermath
The decision reduced Solvay’s TFA-related manufacturing footprint and formed part of a broader effort to simplify and reposition the fluorine business.
Source
2022
Separate essential chemistry from specialty activitiesStrategy
Background
Solvay concluded that its essential-chemistry and specialty-chemicals businesses would have clearer strategies and more flexibility as independent listed companies.
Action taken
The company announced a plan to create two independent entities: Solvay for essential chemistry and Syensqo for specialty chemicals and advanced materials.
Aftermath
Shareholders approved the plan in 2023, and the partial demerger was completed in December 2023. Solvay became a more focused essential-chemistry company.
Source
2015
Acquire Cytec IndustriesM&A
Background
Solvay aimed to accelerate growth in advanced materials, aerospace and automotive composites, mining chemicals, and other higher-value formulations.
Action taken
Solvay agreed to acquire all of Cytec’s share capital for US$75.25 per share in cash and completed the transaction in December 2015.
Aftermath
Cytec strengthened Solvay’s position in aerospace composites and mining chemicals and became the group’s largest acquisition. The deal required a major capital increase and additional hybrid and debt financing.
Enterprise value. Approximately US$6.4 billion; approximately US$5.5 billion cash consideration (Announced July 2015; completed December 2015)
Source
2011
Acquire RhodiaM&A
Background
Solvay sought to diversify beyond traditional heavy chemicals and expand its specialty-chemicals, consumer, automotive, rare-earth, and international activities.
Action taken
Solvay completed the acquisition of French chemical company Rhodia for approximately €3.4 billion.
Aftermath
Rhodia became a major foundation of Solvay’s transformation and brought Jean-Pierre Clamadieu into the chief executive role in 2012.
Transaction value. Approximately €3.4 billion (Agreement announced April 2011; transaction completed September 2011)
Source
2009
Sell the pharmaceutical division to AbbottM&A
Background
Solvay decided to exit pharmaceuticals and concentrate its capital and management attention more heavily on chemicals and materials.
Action taken
The company agreed to sell its pharmaceutical activities to Abbott Laboratories for approximately €4.5 billion, with completion in February 2010.
Aftermath
The divestment provided resources for Solvay’s subsequent acquisition-led transformation, including the purchase of Rhodia.
Transaction value. Approximately €4.5 billion (Announced September 2009; completed February 2010)
Source

Recent events

2025
Solvay reports 2025 portfolio and operating changes[4]Solvay 2025 Annual Integrated Reportsolvay.com
Other
The 2025 annual report described the post-demerger group as operating 43 production sites and six research centers in more than 41 countries, with approximately 8,400 employees. It also disclosed planned discontinuation of selected Bad Wimpfen product lines and the planned closure of the Garbsen site by 2028.
2025
Solvay receives damages in automotive-catalyst patent litigation[4]Solvay 2025 Annual Integrated Reportsolvay.com
Lawsuit · Other
Solvay’s 2025 annual report stated that a court awarded the company €10.3 million in damages plus €1.3 million in procedural interest in a patent-infringement case relating to automotive catalyst materials.
2024
Solvay begins European rare-earth production for permanent magnets[9]Solvay rare-earth production expansionsolvay.com
Product launch
The company inaugurated an expanded production line at La Rochelle, France, to supply rare-earth materials used in permanent magnets for electric vehicles, renewable-energy equipment, electronics, and defense applications.
2024
Solvay stops production of trifluoroacetic acid at Salindres[2]Solvay official company overviewsolvay.com
Regulation · Product generation
Solvay reported that it stopped TFA production at its Salindres, France, site in September 2024 and planned to phase out remaining TFA-related production at Bad Wimpfen, Germany, by early 2026.
2023
Solvay completes partial demerger and creates Syensqo[5]Solvay partial demerger informationsolvay.com
M&A
Solvay separated its specialty-chemicals and advanced-materials activities into Syensqo, while retaining essential chemistry businesses such as soda ash, bicarbonates, peroxides, silica, selected fluorine activities, and rare earths.

Sources25 sources

Cite this profile: Cite the canonical profile. /brand-wiki/solvay · Editorial policy · How profiles are compiled